Symptoms and diagnostic delay in ovarian cancer: A summary of the literature

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Contemporary Nurse: health care across the lifespan

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5172/conu.2009.34.1.055PMID 20230172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scottish Intercollegiate Guidelines Network

  2010cited by this paper
• Systematic Reviews and Meta-Analysis

  2008cited by this paper
• Centralisation of services for the management of ovarian cancer

  2008cited by this paper
• The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

  2008cited by this paper
• Identifying symptoms of ovarian cancer: a qualitative and quantitative study

  2008influential reference
• Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

  2008cited by this paper
• A Qualitative Study Examining Psychosocial Distress, Coping, and Social Support Across the Stages and Phases of Epithelial Ovarian Cancer

  2008cited by this paper
• Combining a symptoms index with CA 125 to improve detection of ovarian cancer

  2008cited by this paper
• Symptoms of ovarian cancer in young patients 2 years before diagnosis, a case-control study.

  2008influential reference
• The Cochrane Wounds Group: systematically reviewing the wound care literature.

  2007cited by this paper
• Development of an ovarian cancer symptom index: possibilities for earlier detection.

  2007cited by this paper
• Symptom Clusters and Quality of Life in Survivors of Ovarian Cancer

  2007cited by this paper
• Development of an ovarian cancer symptom index

  2007influential reference
• Temporal Patterns of Conditions and Symptoms Potentially Associated with Ovarian Cancer

  2007cited by this paper
• Early Detection of Ovarian Cancer

  2007cited by this paper
• Development of an ovarian cancer symptom index: Possibilities for earlier detection

  2007influential reference
• Symptoms, Diagnoses, and Time to Key Diagnostic Procedures Among Older U.S. Women With Ovarian Cancer

  2007influential reference
• Diagnosis and Management of Epithelial Ovarian Cancer

  2006cited by this paper
• A review and an update on the screening of epithelial ovarian cancer.

  2006cited by this paper
• Testing for ovarian cancer.

  2006cited by this paper
• Feasibility of screening for ovarian cancer using symptoms as selection criteria *

  2006cited by this paper
• Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay'.

  2006influential reference
• Screening for ovarian cancer in the general population.

  2006cited by this paper
• Treatments for gynaecological cancers.

  2006cited by this paper
• Symptoms associated with diagnosis of ovarian cancer: a systematic review

  2005cited by this paper
• Ovarian cancer: Can we make the clinical diagnosis earlier?

  2005cited by this paper
• Symptoms and referral of women with epithelial ovarian tumors

  2005influential reference
• Early symptoms of ovarian cancer: a case-control study without recall bias.

  2005influential reference
• Presenting symptoms of epithelial ovarian cancer

  2005influential reference
• An ovarian cancer diagnosis-seeking process: unraveling the diagnostic delay problem.

  2005cited by this paper
• Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer

  2005cited by this paper
• Diagnosis and prognosis of breast and ovarian cancer A population-based study of 234 women

  2004cited by this paper
• Care of elderly women with ovarian cancer.

  2004cited by this paper
• Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer.

  2004influential reference
• Differences in symptoms between patients with benign and malignant ovarian neoplasms.

  2004influential reference
• Symptoms, coping strategies, and timing of presentations in patients with newly diagnosed ovarian cancer.

  2003influential reference
• Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls.

  2003influential reference
• Symptom concerns of women with ovarian cancer.

  2003influential reference
• Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.

  2001cited by this paper
• Symptoms of Ovarian Cancer

  2001cited by this paper
• Symptoms of ovarian cancer.

  2001cited by this paper
• Ovarian carcinoma: care and survival in a community-based population.

  2001cited by this paper
• Ovarian carcinoma diagnosis

  2000influential reference
• Epithelial ovarian cancer: Prevention, diagnosis, and treatment

  1999influential reference
• In Your Skin You are Different: Women Living with Ovarian Cancer During Childbearing Years

  1999cited by this paper
• Ovarian cancer in young women in Sweden, 1989-1991.

  1999cited by this paper
• Canadian women's perspectives on ovarian cancer.

  1999influential reference
• Clinical picture of women with early stage ovarian cancer.

  1999cited by this paper
• Systematic reviews and metaanalysis

  1997cited by this paper
• Delay in diagnosis of epithelial ovarian cancer

  1996cited by this paper
• Early detection of ovarian cancer

  1995cited by this paper
• Development of a code of professional conduct for nurses in Australia

  1995cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

  1994cited by this paper
• Cancer of the ovary.

  1993cited by this paper
• Molecular genetics for the clinician

  1993cited by this paper
• Symptoms and diagnostic difficulties in ovarian epithelial cancer

  1993cited by this paper

• Perioperative nutrition management in stage 4 ovarian cancer patient with high bowel obstruction: a case report

  2026cites this paper
• Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma

  2025cites this paper
• Symptom-related care and diagnoses before ovarian cancer detection: Patterns and differences by cancer stage.

  2025cites this paper
• Gigantic ovarian mucinosa carcinoma: clinical practice in modern oncology

  2025cites this paper
• Histone acetyltransferase 1 promotes ovarian cancer progression by regulating cell proliferation and the cell cycle

  2025cites this paper
• Analysis of inflammation parameter value lymphocyte monocyte ratio (LMR), platelet lymphocyte ratio (PLR), and systemic inflammation response index (SIRI) to differentiate malignant and benign ovarian tumors

  2025cites this paper
• RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer

  2024cites this paper
• Mild symptoms matter: Results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer.

  2024cites this paper
• Time to Diagnosis and Treatment for Ovarian Cancer and Associations with Outcomes: A Systematic Review

  2024cites this paper
• A benzimidazolium salt induces apoptosis and arrests cells at sub-G1 phase in epithelial ovarian cancer cells

  2024cites this paper
• Comprehensive ultrasound diagnosis of ovarian cancer, assessment of its local and distant spread. Part 2. Ultrasound diagnosis of local and distant spread of the tumor process of primary malignant ovarian epithelial tumors. Options. Semiotics. Errors

  2023cites this paper
• Coupled Electrostatic and Hydrophobic Destabilisation of the Gelsolin-Actin Complex Enables Facile Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid

  2023cites this paper
• New trends in diagnosing and treating ovarian cancer using nanotechnology

  2023cites this paper
• Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)

  2022cites this paper
• Multiple Biomarker Simultaneous Detection in Serum via a Nanomaterial-Functionalized Biosensor for Ovarian Tumor/Cancer Diagnosis

  2022cites this paper
• Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort

  2022cites this paper
• Ovarian Cancer Symptom Clusters: Use of the NIH Symptom Science Model for Precision in Symptom Recognition and Management.

  2022cites this paper
• Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer

  2022cites this paper
• Symptoms of Women With High-Risk Early-Stage Ovarian Cancer

  2022cites this paper
• (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers

  2021cites this paper
• Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer

  2021cites this paper
• Nanocarrier‐delivered small interfering RNA for chemoresistant ovarian cancer therapy

  2021cites this paper
• What Do Relatives of Turkish Women with Ovarian Cancer Share on Websites? : A Qualitative Research

  2020cites this paper
• Feelings, thoughts and experiences of women diagnosed with adnexal mass: A qualitative study

  2019cites this paper
• MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B

  2018cites this paper
• Echography in the estimation of the extent of ovarian cancer

  2017cites this paper
• Inadequate critical appraisal of studies in systematic reviews of time to diagnosis.

  2016cites this paper
• Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis

  2016cites this paper
• A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer.

  2016cites this paper
• Méthodologies d’évaluation de l’optimalité des soins : exemples des délais diagnostiques et des infections bactériennes sévères de l’enfant

  2015cites this paper
• Folate modified nanoparticles for targeted co-delivery chemotherapeutic drugs and imaging probes for ovarian cancer

  2015cites this paper
• FREQUENCY AND HISTOLOGICAL SPECTRUM OF MALIGNANT OVARIAN TUMOURS AT KING EDWARD MEDICAL UNIVERSITY, LAHORE

  2015cites this paper
• Symptomization and triggering processes: ovarian cancer patients' narratives on pre-diagnostic sensation experiences and the initiation of healthcare seeking.

  2014cites this paper
• Narrative reviews

  2014cites this paper
• Clinical Brief: Identifying Symptoms of Ovarian Cancer in Chiropractic and Complementary Health Care Settings

  2014cites this paper
• HIF-1alpha Activation in 3D Tumor Spheroids and Evaluation of 2-Methoxyestradiol Therapy using Targeted Nanoparticle Formulations

  2013cites this paper
• Altchek's Diagnosis and Management of Ovarian Disorders: Clues to ovarian tumors: new concepts of symptoms, signs, syndromes, and paraneoplastic syndromes

  2013cites this paper
• Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example

  2013cites this paper
• A Complementary Care Study Combining Flaxseed Oil, Caffeine, Fasting, and Exercise in Women Diagnosed with Advanced Ovarian Cancer: Findings from a Case Study

  2012cites this paper
• New Applications of Soft Computing in Bioinformatics : A Review

  2012cites this paper
• Signs of aging or the vague symptoms of ovarian cancer?

  2012cites this paper
• Women'S Awareness of Cancer Symptoms: A Review of the Literature

  2012cites this paper
• Management of Ovarian Cancer and Soft Tissue Sarcoma: Focus on Trabectedin

  2011cites this paper
• Le programme Survivors Teaching Students : une sensibilisation accrue au cancer de l’ovaire

  2011cites this paper
• General practitioner referral patterns for women with gynaecological symptoms: a randomised incomplete block study design

  2011cites this paper
• Survivors teaching students: increasing awareness about ovarian cancer.

  2011cites this paper
• Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.

  2011cites this paper